Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 3 years
- Director since
- 2024
3 years of board service in total across 2 boards, counting each seat separately. Longest: Tempus AI Inc., 2 years.
Tempus AI Inc.
Director
AgomAb Therapeutics NV
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Tempus AI Inc. May 21, 202695.6%
-
Tempus AI Inc. May 20, 202595.3%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 1, 2026 | Tempus AI Inc. | Open-market sale | −250 | $65.55 | $16,388 |
| Aug 3, 2026 | Tempus AI Inc. | Open-market sale | −370 | $43.40 | $16,058 |
| Jun 1, 2026 | Tempus AI Inc. | Open-market sale | −250 | $49.40 | $12,350 |
| May 21, 2026 | Tempus AI Inc. | Grant or award | +5,913 | — | — |
| Mar 2, 2026 | Tempus AI Inc. | Open-market sale | −250 | $50.69 | $12,673 |
| Feb 2, 2026 | Tempus AI Inc. | Open-market sale | −370 | $59.41 | $21,982 |
| Dec 1, 2025 | Tempus AI Inc. | Open-market sale | −250 | $75.55 | $18,888 |
| Nov 3, 2025 | Tempus AI Inc. | Open-market sale | −370 | $90.00 | $33,300 |
| Sep 2, 2025 | Tempus AI Inc. | Open-market sale | −250 | $73.64 | $18,410 |
| Aug 1, 2025 | Tempus AI Inc. | Open-market sale | −370 | $55.16 | $20,409 |
| Jun 2, 2025 | Tempus AI Inc. | Open-market sale | −250 | $55.20 | $13,800 |
| May 20, 2025 | Tempus AI Inc. | Grant or award | +1,997 | — | — |
| May 1, 2025 | Tempus AI Inc. | Open-market sale | −370 | $53.50 | $19,795 |
| Mar 17, 2025 | Tempus AI Inc. | Open-market sale | −990 | $46.83 | $46,362 |
| Mar 3, 2025 | Tempus AI Inc. | Open-market sale | −250 | $57.52 | $14,380 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.